Blodplasma används som läkemedel. : Men nationella, evidensbaserade behandlingsriktlinjer saknas
There are great regional variations in the use of plasma products. Evidence-based guidelines for plasma treatment are lacking. The Swedish market offers a non-commercial plasma product, produced by the hospital-based transfusion departments. There is also the commercial, virus-inactivated “SD plasma”. This is more expensive than the non-commercial plasma, yet it has not been shown to reduce the ri
